logo
Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts

Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts

Business Wire22-07-2025
BEAVERTON, Ore.--(BUSINESS WIRE)--Datavault AI Inc. (NASDAQ: DVLT), a leader in data visualization, valuation, and monetization technologies, today announced a strategic partnership with Burke Products ('Burke'), a minority-owned Tier 1 supplier to Lockheed Martin (NYSE: LMT), Raytheon Technologies (NYSE: RTX), Department of Defense, Original Equipment Manufacturers (OEMs), and the Defense Logistics Agency as well as their international allied force corollaries. The partnership stands to deliver 2025 Revenues from existing contracts of Burke's that have now been subcontracted to Datavault AI and is set to scale into productized offerings into 2026.
Within the partnership Datavault AI has been contracted by Burke Products to engineer and produce solutions responsive to an array of opportunities. All opportunities are managed under the contract in a case-by-case fashion designed to be responsive to private and public RFPs and requests made directly and through subcontracts obtained by Burke and other contracting mechanisms in place at Burke Products on a global basis.
Military grade engineering, manufacturing and productization is now underway. The collaboration aims to advance defense and aerospace capabilities by integrating Datavault AI's services and proprietary data and ADIO® tone technologies with Burke's experienced manufacturing and engineering teams to accelerate productization and speed to market that Datavault AI's technologies have been designed to automate and support at scale.
According to Janes, global defense spending is projected to exceed $2.2 trillion in 2025, with the U.S. defense budget alone expected to surpass $900 billion. As modernization efforts escalate, the sector is increasingly focused on secure data solutions, advanced tracking, and predictive intelligence—areas where Datavault AI is uniquely positioned to deliver for Burke new and innovative solutions that solve for advantages and forward progression of technologies in this sector. With Web 3.0 centric contributions of Datavault AI this partnership will explore technological synergies with particular emphasis on secure data management, resource tracking, and communication systems critical to mission success.
Aaron Bakhshi, CEO of Burke Products, shared his outlook on the business alliance and licensing contracts now in place with Datavault AI, 'For more than 59 years, Burke Products has supplied advanced electro-mechanical components and assemblies to leading defense and aerospace partners, including Lockheed Martin, Raytheon Technologies, Northrop Grumman, General Dynamics, the U.S. Navy, the Defense Logistics Agency, and their allied international counterparts. As a minority-owned defense contractor committed to engineering innovation, we view this strategic alliance with Datavault AI as a transformative step toward future-ready solutions. The introduction and demonstrations of Datavault's solutions into our product portfolio marks a significant evolution in how we approach innovation across mission-critical systems.'
Bakhshi continued: 'This collaboration originated from Sonia Choi's ability to identify and align mutual strategic interests, particularly around innovations in acoustic sciences and separately, the urgent challenge of addressing stolen valor—two distinct areas where Datavault AI's platform provides an elegant and effective solution. Additionally, our shared vision around the scalable deployment of Digital Twin technologies further strengthens the foundation of this partnership and unlocks significant future potential. Her skill in connecting advanced technology to real-world defense applications and viable business models was instrumental in forming this agreement. It resonates with me, as it reflects the executive vision and innovation that Burke Products strives to champion across all of our initiatives. We believe the work underway with Datavault AI will deliver measurable value to our clients and help redefine operational standards across multiple defense verticals with new Web 3.0 solutions.'
The first phase will integrate Datavault AI's acoustic sciences services and products, including patented ADIO® tone technology, into Burke's pre-existing systems. Future phases may expand into integrating Datavault AI's proprietary data solutions for digital twin modeling, predictive analytics, inventory logistics and management as well as blockchain-based can tools to secure supply chains and authenticate critical components throughout their lifecycle.
'It has been an honor to work with and partner alongside Aaron Bakhshi and Burke Products to help extend Datavault AI's orchestrated blend of talent and technological footprint into the defense sector,' said Sonia Choi, Co-Founder and CMO of Datavault AI and Lead Principal Investigator on a privately funded Strategic Partnership Project facilitated through the U.S. Department of Energy's Brookhaven National Laboratory.
'Burke Products has a rare and profound legacy of combining engineering precision with innovation—qualities that immediately resonated with our shared commitment to mission-critical performance. We are both builders and systems thinkers, capable of harnessing our technologies to automate high-value solutions in environments defined by complexity and zero tolerance for error. By leveraging our advanced data and acoustic sciences to solve real-world problems and by aligning our ecosystems together, we're laying the groundwork for scalable, American-built solutions. This marks a pivotal step and underscores Datavault AI's strategic entry into, and sustained relevance within, modern defense infrastructure,' stated Sonia Choi.
As the defense and aerospace sectors rapidly evolve, this partnership marks a significant milestone. With a focus on security, precision, and next-gen data integration, Datavault AI and Burke Products are working together to shape the future of national defense technology.
Nathaniel T. Bradley, Co-Founder and CEO of Datavault AI, asserted: ' This collaboration marks an international milestone of a scale we couldn't have anticipated when we first founded the company. Sonia Choi has been diligently building toward this moment for years, and her ability to identify high-impact applications for Datavault AI's technologies—while guiding our team through the execution with focus and discipline—has been exceptional. Through her vision and leadership, we've reached a breakthrough that aligns seamlessly across our VerifyU, ADIO®, High Performance Computing, WiSA and Datavault platforms, in concert with Burke Products' expansive capabilities, trusted network, and precision-driven engineering excellence.'
Bradley noted, 'Together, with Burke Products, we now have an industry leading, solutions-oriented contracting partner that not only understands Datavault AI's mission, but is equipped to deliver defense-grade, purpose-built innovations when they are most needed. Sonia's and Aaron's influence will have a lasting impact—not only on Datavault AI's trajectory, but on the broader U.S. defense industry it serves. We're deeply grateful to Burke Products for validating our intellectual property, recognizing the strength of our team, and stepping forward with us to realize the full potential of this partnership.'
About Datavault AI Inc.
Datavault AI TM (Nasdaq: DVLT) is leading the way in AI driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features WiSA®, ADIO® and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI's cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange® (IDE) enables Digital Twins, licensing of name, image and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more about Datavault AI at www.dvlt.ai.
About Burke Products, Inc.
Burke Products, Inc. is a minority-owned manufacturer of high-precision electro-mechanical components and assemblies, serving the aerospace and defense sectors for over 59 years. The company has established a longstanding reputation for reliability and excellence across critical supply chains, maintaining established relationships with clients including the U.S. Department of Defense, Defense Logistics Agency (DLA), Lockheed Martin, Raytheon Technologies, Honeywell, General Dynamics, Goodrich, and Johnson & Johnson. Internationally, Burke has fulfilled government contracts and procurement programs for India and our allied defense partners in the UK, Japan, Germany, Turkey, and many others. Operating under ISO and AS-compliant quality systems, Burke specializes in contracted manufacturing, acoustic systems and technology integration, and rapid design-to-production capabilities for defense-grade hardware. Its core competencies support both domestic and allied military readiness through scalable, high-integrity supply partnerships.
To learn more about Burke Products, please visit https://burkeproducts.com/.
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws. Words such as "expect," "will," "anticipates," "estimates" and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Such forward-looking statements, including statements herein regarding our business opportunities and prospects, strategy, future revenue expectations, licensing initiatives, recent funding and M&A activities as well as our plans to integrate acquired businesses and technologies, are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: the risk that we are unable to satisfy all closing conditions in connection with the senior notes issuance described above, and the acquisition of certain assets from CSI; our ability to successfully integrate all IP that we have acquired; risks regarding our ability to utilize the assets we acquire to successfully grow our market share; risks regarding our ability to open up new revenue streams as a result of the various agreements we have entered into and assets we have acquired; our current liquidity position and the need to obtain additional financing to support ongoing operations; general market, economic and other conditions; our ability to continue as a going concern; our ability to maintain the listing of our common stock on Nasdaq; our ability to manage costs and execute on our operational and budget plans; our ability to achieve our financial goals; the degree to which our licensees implement the licensed technology into their products, if at all; the timeline to any such implementation; risks related to technology innovation and intellectual property, and other risks as more fully described in our filings with the U.S. Securities and Exchange Commission. The information in this press release is provided only as of the date of this press release, and we undertake no obligation to update any forward-looking statements contained in this communication based on new information, future events, or otherwise, except as required by law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?
UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?

Yahoo

time27 minutes ago

  • Yahoo

UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?

Key Points UnitedHealth's recent numbers showed a deep decline in profit. The company's earnings forecast for 2025 came in well below analyst expectations. The stock is trading at a significant discount and is well below where it has been in recent years. 10 stocks we like better than UnitedHealth Group › Things are going from bad to worse for UnitedHealth Group (NYSE: UNH). Investors were already enduring a tough year in 2025, with the company facing myriad bits of bad news, including poor financial results, a change in CEO, and an investigation involving the Department of Justice. Then, the company reported its latest earnings numbers last Tuesday, and shares fell again. As of the close of trading on July 31, the stock had lost half of its value in 2025. And worst of all, it may not have bottomed out just yet. After the company's recent earnings report, which featured even more bad news, investors shouldn't be surprised to see this struggling stock fall even lower in the weeks and months ahead. Are you better off simply avoiding it, or could UnitedHealth actually make for a good contrarian investment? UnitedHealth's forecast badly missed expectations On July 29, UnitedHealth reported its latest earnings numbers, and while the business was growing, its bottom line wasn't. Revenue for the period ending June 30 totaled $111.6 billion and rose by a modest 2% from the same period last year. But what was concerning was that its earnings (the bottom line), which totaled $5.2 billion, were down a staggering 43%. A big problem for the health insurer is rising medical costs. Its medical care ratio rose from 85.1% a year ago to 89.4% this past quarter, which signifies that it's paying out a higher amount of medical expenses relative to the premiums it collects. The higher the ratio, the less profitable the company. In recent years, patients have been resuming treatments and electing to take surgeries that they put off during the earlier days of the pandemic, which has contributed to this increase. Earlier this year, the healthcare company suspended its guidance amid uncertainty around healthcare costs. But under CEO Stephen Hemsley, who took over from Andrew Witty a few months ago, it has released new guidance. The problem is, it's far below what analysts were expecting. UnitedHealth's adjusted earnings per share is projected to come in at $16 or better this year, but Wall Street was expecting $20.91 in adjusted per-share profit. Unsurprisingly, amid such a drastic shortfall, the stock proceeded to drop yet again after the news. How cheap is UnitedHealth stock right now? Shares of UnitedHealth haven't been trading this low since the COVID-19 crash of 2020. Its five-year return is now -16% before factoring in dividends. Based on analyst earnings estimates, the stock is trading at a forward price-to-earnings multiple of 13. But if analysts reduce their expectations for the stock, then that earnings multiple could end up rising. Based on the company's trailing earnings, investors are paying a multiple of around 11. The chart below shows just how extremely low that is compared to where UnitedHealth stock has traded in the past. The stock is trading at a significant discount and could potentially make for an intriguing investment option. Should you avoid UnitedHealth stock, or take a chance on it? Things look bleak for UnitedHealth's stock as the bad news just keeps coming. But if you're willing to take a contrarian position in the company, be patient, and plan to hang on for multiple years, it may not be a bad move to invest in the business today. Given how significantly discounted it is, there's a good margin of safety here for investors. Consider that the average stock on the S&P 500 trades at a price-to-earnings multiple of 25 -- UnitedHealth is nowhere near that. It could take time for the business to turn things around, but it is working on improving profitability, including exiting some Medicare Advantage markets to curb costs. And with an attractive dividend that yields more than 3% as I write this, there's plenty of incentive just to buy and wait. There's some risk with the stock, but I think the sell-off is a bit overblown. While I wouldn't expect a quick turnaround, UnitedHealth can be a good long-term stock to buy on weakness. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Piper Sandler: Tesla (TSLA) Jury Ruling Is No Reason to Panic
Piper Sandler: Tesla (TSLA) Jury Ruling Is No Reason to Panic

Yahoo

time32 minutes ago

  • Yahoo

Piper Sandler: Tesla (TSLA) Jury Ruling Is No Reason to Panic

Tesla, Inc. (NASDAQ:TSLA) is one of the . On August 4, Piper Sandler analyst Alexander Potter reiterated an "Overweight" rating on the stock with a $400.00 price target. The firm said investors shouldn't be over-reacting to headlines surrounding Tesla's recent Autopilot-related jury verdict in Florida. It believes the case is less significant than it seems. 'In our years covering TSLA, we've learned to ignore headlines related to Autopilot liability. But the robotaxi roll-out has breathed new life into this topic, and we feel compelled to comment on recent media intrigue. On Friday, when a jury in Florida found Tesla partially liable for a 2019 crash, headlines began proliferating, referring to a 'stunning rebuke', a 'massive blow', and a $243M obligation. In our view, these headlines paint an unrealistically negative picture. In short, we don't think shareholders should be losing sleep over this.' Pixabay / Public Domain Tesla, Inc. (NASDAQ:TSLA) is an automotive and clean energy company that leverages advanced artificial intelligence in its autonomous driving technology and robotics initiatives. While we acknowledge the potential of TSLA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Must-Watch AI Stocks on Wall Street and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Datadog (DDOG) Up 54%—Analyst Still Bullish Heading Into Q2 Results
Datadog (DDOG) Up 54%—Analyst Still Bullish Heading Into Q2 Results

Yahoo

time32 minutes ago

  • Yahoo

Datadog (DDOG) Up 54%—Analyst Still Bullish Heading Into Q2 Results

Datadog, Inc. (NASDAQ:) is one of the . On August 4, UBS analyst Karl Keirstead reiterated a 'Buy' rating on the stock with a $165.00 price target. The company is expected to report earnings for the fiscal quarter ending June 2025 on 08/07/2025 before market open. The firm believes that Datadog is heading into earnings with strong cloud tailwinds overblown concerns regarding OpenAI. However, the recent 54% rally since early April makes the stock less compelling. 'Ahead of Datadog's 2Q25 print on Thursday morning, we review the key debates, including overall observability software spending trends, the health of the OpenAI-Datadog relationship and the impact of the (slightly) disappointing AWS results." Here's why the firm is still leaning positive to Datadog: "While the 54% rally in the stock since early-April (the shares are back to 12x/42x on CY26E revs/FCF) makes the set-up less compelling, we still lean positive given Datadog's correlation to a very healthy cloud infra market as well as our view that the Street is over-indexing too negative on the OpenAI risk.' Datadog, Inc. (NASDAQ:DDOG) offers a cloud-based SaaS platform for monitoring and analytics, specializing in cloud computing and AI-powered cybersecurity products. While we acknowledge the potential of DDOG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Must-Watch AI Stocks on Wall Street and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store